INBSINTELLIGENT BIO SOLUTIONS INC.

Nasdaq gbs.inc


$ 1.79 $ 0.01 (0.38 %)    

Tuesday, 02-Jul-2024 13:57:02 EDT
QQQ $ 486.52 $ 5.06 (1.05 %)
DIA $ 393.25 $ 1.83 (0.47 %)
SPY $ 548.30 $ 3.67 (0.67 %)
TLT $ 90.61 $ 0.70 (0.78 %)
GLD $ 215.57 $ -0.01 (0 %)
$ 1.84
$ 1.82
$ 1.82 x 250
$ 1.86 x 300
$ 1.79 - $ 1.82
$ 1.76 - $ 39.48
24,151
na
3.83M
$ 2.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-09-2024 12-31-2023 10-Q
3 11-08-2023 09-30-2023 10-Q
4 08-23-2023 06-30-2023 10-K
5 05-11-2023 03-31-2023 10-Q
6 02-14-2023 12-31-2022 10-Q
7 11-14-2022 09-30-2022 10-Q
8 09-22-2022 06-30-2022 10-K
9 05-16-2022 03-31-2022 10-Q
10 02-10-2022 12-31-2021 10-Q
11 11-12-2021 09-30-2021 10-Q
12 09-16-2021 06-30-2021 10-K
13 05-13-2021 03-31-2021 10-Q
14 02-12-2021 12-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 intelligent-bio-solutions-to-implement-strategic-reorganization-plan-to-support-global-growth-initiatives

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...

 intelligent-bio-solutions-q3-eps-143-beats-252-estimate

Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(1.43) per share which beat the analyst consensus estimat...

 intelligent-bio-solutions-inc-files-for-offering-of-up-to-68m-shares-by-the-selling-stockholders

 - SEC Filing

 intelligent-bio-solutions-partners-with-cliantha-research-to-conduct-clinical-study-as-part-oof-fda-510k-pathway

Intelligent Bio Solutions Inc. ("INBS" or the "Company") (NASDAQ:INBS), a medical technology company delivering...